🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human urinary kallidinogenase can promote the establishment of collateral c...
Status
Completed
Location
Department of Neurolgy,Xuanwu Hospital of Capital Medical University
Start Date
2013-01
Trial ID
NCT02259738
Treatments Being Tested
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics o...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-10
Trial ID
NCT06344533
Treatments Being Tested
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
The purpose of this study is to evaluate time to progression, overall survi...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00103506
Treatments Being Tested
The primary objective is to demonstrate the efficacy of ferric carboxymalto...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-07-03
Trial ID
NCT03591406
Treatments Being Tested
The aim of the TRICIDIA2 study is to compare two modalities of administrati...
Status
Unknown
Location
CHU
Start Date
2012-01
Trial ID
NCT01889914
Treatments Being Tested
The primary objective of the study was to evaluate the safe and effective u...
Status
Completed
Location
Research Site
Start Date
2009-01
Trial ID
NCT00828204
This study will evaluate the safety and efficacy of an intravitreal insert ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00344968
Treatments Being Tested
There is no standard treatment for chondrosarcoma. Some small sample of stu...
Status
Unknown
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-02-06
Trial ID
NCT05193188
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested